Our Backbone: Cancer Centres

The backbone of the 3CTN initiative are the member sites that collaborate and communicate via our innovative Network structure.

EXPLORE THE NETWORK

Our Voice: Patient Representatives

Patient Representatives can contribute a crucial perspective to clinical trials by providing feedback, insight, expertise and support towards trial activities and initiatives.

LEARN ABOUT OUR PATIENT REPRESENTATIVE COMMUNITY

Coordinating Centre

At the pinnacle of the Network, The 3CTN Coordinating Centre acts as the leadership and communication hub for the Network and is responsible for supporting and coordinating activities at the Network sites, in order to reach the Network’s goals and objectives.

Janet Dancey, MD
Scientific Director

Bernie Eigl, MD
Associate Scientific Director

Gerald Batist, MD
Associate Scientific Director

Stephen Sundquist
Executive Director

Lam Pho
Director, Information Technology

Diana Kato
Manager, Operations

Saher Lalani
Project Financial Analyst

Rebecca Xu
Manager, Portfolio and Informatics

James Schoales
Portfolio Data Coordinator

Our Governance

Each committee in our governance brings expert knowledge at a high level, which is crucial to the success of 3CTN as it provides a link to the broader Canadian cancer research environment with the aim of maintaining 3CTN’s relevance and sustainability.

Scientific Advisory Board

David Cameron, MD
Chair, Breast International Group

Gavin Stuart, MD
Professor, Division of Gynecologic Oncology, University of British Columbia

Patrick Sullivan
Patient Representative

Judy Needham
Patient Representative

Rachel Syme, Ph.D
Assistant Director, Institute of Cancer Research, Canadian Institutes of Health Research

Stephen Sundquist
Executive Director, 3CTN

Janet Dancey, MD
Scientific Director, 3CTN

Funders Oversight Committee

Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University

Rami Rahal
Vice President, Cancer Systems, Performance and Innovation, Canadian Partnership Against Cancer

Christy Holtby
Vice President, Philanthropy, Alberta Cancer Foundation

Megan Lee
Vice President, Program Investment (Acting), Alberta Cancer Foundation

Gerald Batist, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)

Bernie Eigl, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency

Antonia Palmer
Patient Representative

Krista Rideout
Interim Director, Division of Clinical Research, Eastern Health

Kathryn Dyck
Manager, Clinical Trials Unit, CancerCare Manitoba

Christine Williams, PhD
Deputy Director and Head, Clinical Translation, Ontario Institute for Cancer Research

Stephen Sundquist
Executive Director, 3CTN

Janet Dancey, MD
Scientific Director, 3CTN

Management and Executive (*) Committee

Ian Tannock*, MD (Chair)
Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre

Janet Dancey*, MD
Scientific Director, 3CTN

Bernie Eigl*, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency

Annette Cyr*
Patient Representative and Chair, Melanoma Network of Canada

Gerald Batist*, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)

Tracie Hanna
Manager, Cancer Clinical Research Team, Kingston Health Sciences Centre

Joseph Pater, MSc, MD
Emeritus Professor, Queen’s University

Jim Pankovich
Vice President, Clinical Operations & Drug Development, Qu Biologics

Patricia Tang, MD
Clinical Assistant Professor, Department of Oncology, Tom Baker Cancer Centre

Jim Whitlock, MD
Division Head, Haematology/Oncology, The Hospital for Sick Children

Joel Gingerich, MD
Medical Director, Community Oncology, CancerCare Manitoba

John Thoms, MD
Physician Director, Clinical Trials, Dr. H. Bliss Murphy Cancer Centre

Stephen Sundquist
Executive Director, 3CTN

Lam Pho
Director, Information Technology, 3CTN

Our Operating/Advisory Committees

Portfolio Committee

This team is responsible for reviewing the criteria for trial entry into the Portfolio and metrics for trial retention within the Portfolio; and reviewing the trial Portfolio for scientific merit, priority, performance and strategic balance to cover the range of trials of interest/relevance to Canadians and the Canadian health care system.

Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University

Stephen Chia, MD
Medical Oncologist, BC Cancer Agency, Vancouver Clinic

Lynn Dwernychuk
Provincial Leader, Clinical Research, Saskatchewan Cancer Agency

Julie Lemieux, MD
Medical Oncologist, CHU de Quebec

Judy Needham
Patient Representative, British Columbia

Carol Portwine, MD
Associate Professor, Department of Pediatrics, McMaster University

Krista Rideout
Manager, Clinical Research, Eastern Health

Jim Wright, MD
Radiation Oncologist, Juravinski Cancer Centre

Janet Dancey, MD
Scientific Director, 3CTN

Stephen Sundquist
Executive Director

Rebecca Xu
Manager, Portfolio and Informatics

James Schoales
Portfolio Data Coordinator

Performance Strategy Team

This team is responsible for evaluating Network performance, identifying problems and proposing new initiatives, tools to improve the efficiency and quality of trial activities, improvements to and competencies of clinical trial staff through education, training and mentoring and greater patient access to trials.

Marie-Chantal Delisle
Project Manager, Clinical Research Network, Q-CROC

Lynn Dwernychuk
Director, Clinical Research, Saskatchewan Cancer Agency

Kathryn Dyck
Clinical Trials Manager, CancerCare Manitoba

Carla Girolametto
Director, Innovation and Research and Clinical Trials, Grand River Hospital

Tracie Hanna
Clinical Manager, Kingston Health Sciences Centre

Brenda Kowaleski
Clinical Trials Manager, Juravinski Cancer Centre

Dora Nomikos
Manager, Trial Management Group, Canadian Cancer Trials Group

Alison Van Nie
Research Ethics Officer, Ontario Institute for Cancer Research

Philip Pollock
Manager, Clinical Trials & Clinical Research, Vancouver Island Centre, BC Cancer

Debra Walker
Patient Representative

Stephen Sundquist
Executive Director, 3CTN

Patient Representative Advisory Committee (PRAC)

The PRAC is a team of 3CTN Patient Representatives and 3CTN CC staff with the focus of providing feedback, insight, expertise and support to the Network.

Fred Clark (Chair)
Manitoba

Gretta Hutton
Ontario

Louis Gagne
Quebec

Jean Francois Denault
Quebec

Stephanie Mayne
Newfoundland

Alison Stoneman
Ontario

Nelson Picard
Quebec

Stephen Sundquist
Executive Director, 3CTN

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators

CONTACT US ABOUT PARTNERSHIPS